文献速递瓣膜外科冠心病外科

退行性二尖瓣合并冠状动脉手术的早期结局与10年生存

Combined Degenerative Mitral Valve and Coronary Surgery: Early Outcomes and 10-Year Survival.
PubMed 文献 · Ann Thorac Surg · 2020-04-08

研究比较退行性二尖瓣病变患者行DMV+CABG联合手术与单纯DMV手术的院内结局和10年生存,纳入745例患者,其中186例(24.9%)接受联合手术。倾向性评分匹配分析显示两组复合终点和10年生存率无显著差异,二尖瓣修复与更好的短期结局和长期生存相关。

要点

  • DMV+CABG联合手术的院内复合终点与单纯DMV手术相当
  • 匹配分析中两组10年生存率无显著差异
  • 无论是否合并冠状动脉手术,二尖瓣修复均与更优长期生存相关

核心结论

  • DMV+CABG联合手术是有效的治疗方式,二尖瓣修复率高,早期院内结局和长期生存与单纯DMV手术相当。
  • 在联合手术中,二尖瓣修复与更好的长期生存相关。

研究设计与样本

  • 回顾性队列研究,纳入745例退行性二尖瓣病变患者,其中186例(24.9%)合并冠心病接受DMV+CABG,其余559例接受单纯DMV手术。
  • 采用倾向性评分匹配分析以减少偏倚,比较院内复合终点及1年、5年、10年生存率。

主要发现

  • 未匹配分析中复合终点发生率DMV+CABG组6.5% vs 单纯DMV组5.4%(P = .71)。
  • 匹配分析中复合终点发生率7.5% vs 8.2%(P = .82)。
  • 未匹配分析10年生存率70.5% vs 68.6%(P = .07)。
  • 匹配分析10年生存率64.6% vs 62.5%(P = .9)。
  • 二尖瓣修复对短期结局和长期死亡率有益,无论是否合并冠状动脉手术。

临床怎么用

  • 对于退行性二尖瓣病变合并冠心病的患者,可考虑行DMV+CABG联合手术,其早期和长期结局与单纯DMV手术相当。
  • 在联合手术中应优先尝试二尖瓣修复,因为修复与更好的长期生存相关。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: This study investigated the impact of combined degenerative mitral valve (DMV) and coronary artery bypass grafting (CABG+DMV) surgery vs DMV surgery only on in-hospital health outcome and 10-year survival. METHODS: We identified 745 patients with DMV disease. Of these, 186 (24.9%) were affected also by coronary disease and underwent combined DMV+CABG. They were compared with the remaining 559 patients receiving DMV-only surgery in in-hospital and 1-, 5-, and 10-year survival. We evaluated a short-term composite outcome of hospital mortality, acute kidney injury, cerebrovascular events, and low cardiac output requiring postoperative use of intraaortic balloon pump. In addition, we assessed mitral valve repair rates over time and their correlation with long-term survival. To minimize bias, we conducted a propensity score-matching analysis. RESULTS: DMV+CABG surgery was associated with a similar incidence of the composite end point compared with DMV-only surgery in the unmatched analysis (6.5% vs 5.4%, P = .71) and matched analysis (7.5% vs 8.2%, P = .82). The 10-year survival was 70.5% vs 68.6% (P = .07) for the unmatched analysis and 64.6% vs 62.5% (P = .9) for the matched analysis, DMV+CABG vs DMV-only, respectively. Mitral valve repair had a beneficial effect on short-term outcomes and long-term mortality rates, regardless the presence of concomitant coronary surgery. CONCLUSIONS: Combined DMV+CABG surgery is a very effective surgical treatment with high mitral valve repair rate. Early in-hospital outcome and long-term survival are comparable with DMV-only surgery. In these combined procedures, mitral valve repair is associated with better long-term survival.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Bruno VD, Zakkar M, Guida G, et al. Combined Degenerative Mitral Valve and Coronary Surgery: Early Outcomes and 10-Year Survival. Ann Thorac Surg. 2020. PMID: 32277884. doi:10.1016/j.athoracsur.2020.03.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。